Torrance, CA8 Active Studies

Ankylosing Spondylitis Clinical Trials in Torrance, CA

Find 8 actively recruiting ankylosing spondylitis clinical trials in Torrance, CA. Connect with local research sites and explore new treatment options.

8
Active Trials
7
Sponsors
3,001
Enrolling

Recruiting Ankylosing Spondylitis Studies in Torrance

About Ankylosing Spondylitis Clinical Trials in Torrance

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 8 ankylosing spondylitis clinical trials recruiting participants in Torrance, CA. These studies are seeking a combined 3,001 participants. Research is being sponsored by M.A. Med Alliance S.A., Bristol-Myers Squibb, Dompé Farmaceutici S.p.A and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Torrance — FAQ

Are there ankylosing spondylitis clinical trials in Torrance?

Yes, there are 8 ankylosing spondylitis clinical trials currently recruiting in Torrance, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Torrance?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Torrance research site will contact you about next steps.

Are clinical trials in Torrance free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Torrance studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 8 active trials in Torrance are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated July 18, 2026 from ClinicalTrials.gov